Discontinued — last reported Q4 '24
ResMed Net investment gains (losses) decreased by 3410.5% to -$10.13M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 79.4%, from -$5.65M to -$10.13M. Over 3 years (FY 2021 to FY 2025), Net investment gains (losses) shows a downward trend with a -10.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Gains indicate strong performance of financial assets, while losses suggest market downturns or poor investment strategy execution.
This captures the realized and unrealized changes in the fair value of the company's investment portfolio, including equ...
Standard for companies with large treasury departments or captive finance arms.
investment_gains_losses| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.63M | $5.61M | -$4.40M | -$1.74M | -$11.68M | -$3.28M | $8.37M | $6.42M | -$602.00K | -$1.89M | $13.92M | -$15.47M | -$680.00K | -$1.44M | -$5.65M | -$2.53M | -$6.19M | $306.00K | -$10.13M |
| QoQ Change | — | +54.7% | -178.5% | +60.6% | -572.9% | +71.9% | +355.1% | -23.3% | -109.4% | -213.6% | +837.2% | -211.2% | +95.6% | -111.6% | -292.4% | +55.1% | -144.4% | +104.9% | <-999% |
| YoY Change | — | — | — | — | -421.7% | -158.4% | +290.0% | +469.9% | +81.6% | -122.6% | +116.9% | — | -13.0% | +23.8% | -140.6% | +83.6% | -810.3% | +121.3% | -79.4% |